| __timestamp | Amneal Pharmaceuticals, Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 9079000 |
| Thursday, January 1, 2015 | 109679000 | 20309000 |
| Friday, January 1, 2016 | 118757000 | 16945000 |
| Sunday, January 1, 2017 | 109046000 | 20559000 |
| Monday, January 1, 2018 | 230435000 | 29641000 |
| Tuesday, January 1, 2019 | 289598000 | 88258000 |
| Wednesday, January 1, 2020 | 326727000 | 162170000 |
| Friday, January 1, 2021 | 365504000 | 167218000 |
| Saturday, January 1, 2022 | 399700000 | 239528000 |
| Sunday, January 1, 2023 | 429675000 | 94252000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Amneal Pharmaceuticals, Inc. and Galapagos NV, two prominent players, have shown contrasting trends in their SG&A cost management from 2014 to 2023.
Amneal Pharmaceuticals has seen a steady increase in SG&A expenses, peaking at approximately 430 million in 2023, a fivefold increase from 2014. This upward trend suggests a strategic investment in administrative capabilities, possibly to support expansion and innovation. In contrast, Galapagos NV has maintained a more conservative approach, with expenses peaking at around 240 million in 2022, before dropping to 94 million in 2023. This indicates a focus on cost efficiency and streamlined operations.
Understanding these trends provides valuable insights into each company's strategic priorities and operational efficiencies, offering a glimpse into their future trajectories.
Cost Management Insights: SG&A Expenses for Novo Nordisk A/S and Galapagos NV
Breaking Down SG&A Expenses: Johnson & Johnson vs Galapagos NV
Selling, General, and Administrative Costs: AstraZeneca PLC vs Galapagos NV
Biogen Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Insmed Incorporated or Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Galapagos NV
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.
Cost Management Insights: SG&A Expenses for Dynavax Technologies Corporation and Galapagos NV